HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions

doi:10.3748/wjg.v20.i15.4407

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 15

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5647)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

355

WORD

319

HTML

2746

Figures (1-3)

171

Tables (1-1)

168

Sum=3759

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

902

Download

986

Sum=1888

Apr 21, 2014 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Research Report

World J Gastroenterol. Apr 21, 2014; 20(15): 4407-4413
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4407

Full Size Figure Download Figure

Figure 3 Correlation between serum hepatitis B surface antigen levels and hepatitis B virus DNA levels in the three groups of Hepatitis B e antigen-positive chronic hepatitis B patients. A: Immune-tolerant patients (IT) group; B: Patients with a mild immune response in the immune clearance phase (IC-Mild) group; C: Patients with a dramatic immune response in the immune clearance phase and exhibiting acute on chronic liver failure (ACLF) group. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.

Citation: Zhang YM, Yang YD, Jia HY, Zeng LY, Yu W, Zhou N, Li LJ. HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions. World J Gastroenterol 2014; 20(15): 4407-4413
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4407.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4407